Lexotan

Bromazepam, the active ingredient in Lexotan, is a benzodiazepine presented as an oral dosage form for oral administration. It is indicated for the management of anxiety disorders and for short‑term treatment of insomnia that is associated with anxiety, providing symptomatic relief in adult patients.

GNH USA supplies Lexotan as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics across global markets. The company adheres to stringent quality standards and regulatory requirements, ensuring reliable access for healthcare providers worldwide.

Bromazepam, a benzodiazepine, modulates GABA‑mediated neurotransmission in the brain, thereby reducing excessive neuronal activity linked to anxiety and related sleep disturbances. - Anxiety disorders: alleviates excessive worry and tension, improving daily functioning. - Insomnia associated with anxiety: facilitates sleep onset and maintenance in patients whose insomnia is driven by anxiety. - Preoperative anxiety: provides short‑term calming effect before surgical procedures.

Bromazepam may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dizziness: sensation of light‑headedness or unsteadiness. - Memory disturbances: difficulty concentrating or short‑term recall issues. - Fatigue: general lack of energy and increased tiredness. - Impaired coordination: reduced motor control and balance. Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially when combined with other depressants. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Dependence and withdrawal: physical dependence with possible withdrawal symptoms after abrupt cessation.

When prescribing bromazepam, clinicians should consider several precautionary measures to ensure safe use. - Assess medical history: evaluate for respiratory disorders, hepatic impairment, or history of substance abuse. - Use lowest effective dose: start with the smallest dose that provides symptom control. - Avoid abrupt discontinuation: taper gradually to reduce risk of withdrawal. - Caution with CNS depressants: limit concurrent use of alcohol, opioids, or other sedatives. - Pregnancy and lactation: weigh potential risks and benefits before use in pregnant or nursing women. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Bromazepam can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression and sedation. - Barbiturates: additive CNS depression can lead to severe sedation or coma. - Antifungal azoles (e.g., ketoconazole): may increase bromazepam plasma levels, raising toxicity risk. Moderate Interactions (Monitor Closely): - Alcohol: enhances sedative effects, increasing drowsiness and impairment. - Antidepressants (SSRIs, SNRIs): may potentiate central nervous system effects. - Antihistamines: can augment drowsiness and reduced alertness.